Sale is live|00:00:00
Aimco Pesticides LtdQ2 FY20

Aimco Pesticides Ltd

Q2 FY20 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • Current capacity allows for 25-30% growth through de-bottlenecking investments without major CAPEX.
  • Additional CAPEX of around Rs. 4-5 crore planned to increase capacity by 25-30%.
  • Beyond that, new plant investments planned to support new products like Bifenthrin and two others in the pipeline, expected to commercialize in 2-3 years.
  • Bifenthrin volumes expected to scale up materially once registrations in Americas (North & South) are approved.
  • Focus shifting towards higher margin Technical and Branded Formulations, reducing bulk B2B sales.
  • Exports currently ~60% of revenue, expected to remain stable with potential 5-7% variation.
  • Target to achieve ~Rs. 100 crore turnover in Technicals within 2 years.
  • Overall vision is consistent substantial growth, improved profit margins, and becoming a large production-based company with new generic molecules.

Margin guidance

Category 1
  • Expected 25-30% growth from current capacity after de-bottlenecking, without major CAPEX.
  • New plant investment planned for manufacturing two new products, which will drive further topline growth.
  • New product Bifenthrin has high margin potential, expected operating margins better than Chlorpyrifos, safely above 10%.
  • Two more products (an insecticide and a herbicide) are in pipeline, with commercialization expected in 2-3 years.
  • Gross margins expected to improve due to shift from bulk formulated product to higher-margin technical and branded formulations.
  • Operating margins projected to rise above current 10%, aided by new products and better market conditions.
  • Capacity expansion and registration approvals critical for scaling up sales and profitability in exports.
  • The company targets consistent growth and margin improvement over next 3-5 years, focusing on new molecules and export markets.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Aimco Pesticides Ltd and 1,400+ other companies.

Fundraise plans

Yes
- The company raised Rs. 4 crore term loan and Rs. 6 crore working capital loan recently to enhance working capital and support capital investment. - The promoter shareholding was pledged as security for this debt. - There is no indication of immediate further fundraising through debt or equity mentioned. - Future capital expenditures are planned, including about Rs. 2.5 crore on plant de-bottlenecking and Rs. 1.5 crore on effluent treatment, and a new plant investment starting next year for new products. - No explicit mention of additional fundraising for these future CAPEX; current funds and working capital loans appear to cover these. - The company plans to manage working capital prudently and does not intend to carry promoter pledges long-term. In summary, the company has recently taken some debt but no clear plans for new fundraising through debt or equity were stated for the near future.

Order book

  • The company is currently in the development phase for new products and capacities.
  • They have started production of a new product, Bifenthrin, but volume scale-up depends on awaiting registration approvals.
  • Registrations are underway in North and South America; volumes will build up once approvals are received.
  • The company anticipates 25-30% growth from current capacity with ongoing de-bottlenecking investments.
  • For further growth beyond 30%, new manufacturing capacity investments are planned.
  • Contract manufacturing discussions are ongoing, but no capacity available currently; new facility would require separate CAPEX (~Rs. 20-25 crore).
  • The order book is thus linked closely to registration status and market conditions, with expected growth driven by new products' commercialization and capacity expansion.

Capex plans

Yes
  • Currently undertaking CAPEX of about Rs. 4-5 crore: Rs. 2.5 crore for plant debottlenecking and Rs. 1.5 crore for effluent treatment plant to increase capacity by 25-30% without new plant investment.
  • Future CAPEX planned to set up a new plant within the same premises for manufacturing two new products; work on this to start sometime next year.
  • Considering new manufacturing capacities to scale beyond 25-30% growth; currently in development phase.
  • Potential Rs. 20-25 crore large CAPEX for contract manufacturing if undertaken, but requires new facility.
  • Strategic focus on expanding technical product sales and branded formulations with new products in pipeline.
  • Actively investing upfront in product registrations required for exports across various countries.

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
1Aimco Pesticides Ltd
Rev 2Mar 1

See full Fertilizers & Agrochemicals sector rankings

Unlock with Pro

Want more stocks like Aimco Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio